Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-22

Clinical Trial Update: Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery [Phase 1]

View source ↗

Summary

This update reports on a Phase 1 trial of sunitinib given before and after surgery in patients with metastatic kidney cancer that can be removed surgically; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunitinib (sunitinib)

Snippet

Sponsor: Harry Drabkin | Conditions: Kidney Cancer | Phase 1 | Status: TERMINATED